(S (NP (NN Image) (NNS features)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (ADJP (JJ robust) (PP (IN against) (NP (NP (NNS differences)) (PP (IN in) (NP (NN positioning) (, ,) (NN acquisition) (CC and) (NN segmentation)))))) (S (VP (TO to) (VP (VB ensure) (NP (NN reproducibility))))))))) (. .))
(S (NP (NP (NNP Radiomic) (NNS models)) (SBAR (WHNP (WDT that)) (S (ADVP (RB only)) (VP (VBP include) (NP (JJ robust) (NNS features)))))) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB analyse) (NP (JJ new) (NNS images))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NNS models)) (PP (IN with) (NP (JJ non-robust) (NNS features)))) (VP (MD may) (VP (VB fail) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NN interest)))) (ADVP (RB accurately)))))))))))) (. .))
(S (S (VP (VB Test) (HYPH -) (VP (VB retest) (NP (NN imaging))))) (VP (VP (VBZ is) (VP (VBN recommended) (S (VP (TO to) (VP (VB assess) (NP (NN robustness))))))) (, ,) (CC but) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ available) (PP (IN for) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NN interest))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (NP (CD 18) (NNS methods)) (S (VP (TO to) (VP (VB determine) (NP (NN feature) (NN robustness)) (PP (VBN based) (PP (IN on) (NP (NN image) (NNS perturbations)))))))) (. .))
(S (NP (NN Test) (HYPH -) (NML (NN retest) (CC and) (NN perturbation)) (NN robustness)) (VP (VBD were) (VP (VBN compared) (PP (IN for) (NP (NP (CD 4032) (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN computed) (PP (IN from) (NP (NP (DT the) (JJ gross) (NN tumour) (NN volume)) (PP (IN in) (NP (CD two) (NNS cohorts))))) (PP (IN with) (NP (NP (VBN computed) (NN tomography) (NN imaging) (PRN (: :) (NP (PRP I)) (-RRB- -RRB-))) (NP (NP (CD 31) (JJ non-small-cell) (NML (NN lung) (NN cancer)) (-LRB- -LRB-) (NN NSCLC) (-RRB- -RRB-) (NNS patients) (PRN (: ;) (NP (CD II)) (-RRB- -RRB-))) (: :) (NP (CD 19) (NML (NN head) (HYPH -) (CC and) (HYPH -) (NN neck)) (NML (NML (JJ squamous) (NN cell)) (NN carcinoma) (PRN (-LRB- -LRB-) (NP (NN HNSCC)) (-RRB- -RRB-))) (NNS patients))))))))))))) (. .))
(S (NP (NN Robustness)) (VP (VBD was) (VP (VBN measured) (S (VP (VBG using) (NP (DT the) (NN intraclass) (NN correlation) (NN coefficient) (PRN (-LRB- -LRB-) (NP (CD 1,1)) (-RRB- -RRB-))))) (PRN (-LRB- -LRB-) (NP (NN ICC)) (-RRB- -RRB-)))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (DT this) (NN perturbation) (NN chain)) (VP (MD may) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB assess) (NP (NN feature) (NN robustness)))))))) (. .))
